Rinta Ibuki

Title: Rinta Ibuki: Innovator in Sustained-Release Formulations

Introduction

Rinta Ibuki is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of sustained-release technologies. With a total of 10 patents to his name, Ibuki's work has had a substantial impact on drug delivery systems.

Latest Patents

Among his latest patents, Ibuki has developed a sustained-release formulation that includes a solid dispersion composition comprising a tricyclic compound or a pharmaceutically acceptable salt thereof. This formulation is designed to enhance the delivery of medications through a mixture of water-soluble and water-insoluble polymers, along with an excipient. Another notable patent involves a sustained-release formulation containing tacrolimus, which is crucial for preventing organ or tissue rejection in transplantation or treating autoimmune diseases. The formulation is characterized by a specific dissolution time, measured according to the Japanese Pharmacopoeia, ensuring effective drug release.

Career Highlights

Throughout his career, Rinta Ibuki has worked with notable companies in the pharmaceutical industry, including Fujisawa Pharmaceutical Company, Ltd. and Astellas Pharma GmbH. His experience in these organizations has allowed him to refine his expertise in drug formulation and delivery systems.

Collaborations

Ibuki has collaborated with esteemed colleagues such as Fumio Shimojo and Satoshi Ueda. These partnerships have contributed to the advancement of his research and the successful development of innovative pharmaceutical solutions.

Conclusion

Rinta Ibuki's contributions to sustained-release formulations have positioned him as a key figure in the pharmaceutical industry. His innovative approaches continue to influence drug delivery systems, enhancing patient care and treatment outcomes.